EACS Webcast & Video Podcast of the 12th European AIDS Conference / EACS powered by - MULTIWEBCAST

12 presentations / courses

2 Clinical Cases by Iain Reeves 2009-11-11 14 minutes	HIV Testing and Late Diagnosis by Alan McOwan 2009-11-11 31 minutes
2 Clinical Cases 1. Patient with Adherence Issues to ARVs 2. Patient with Sho... by Ann Deschamps 2009-11-11 21 minutes	The Role of the Nurse in the Care and Management of Patients with HIV by Nicky Perry 2009-11-11 27 minutes
2 Clinical Cases by Luigia Elzi 2009-11-11 13 minutes	What and When to Start by Manuel Battegay 2009-11-11 20 minutes
2 Clinical Cases by Michael Aboud 2009-11-11 17 minutes	Short Term Toxicity by Martin Fisher 2009-11-11 30 minutes
Long term Managment, 2 clinical cases by Georg Behrens 2009-11-11 19 minutes	Long Term Toxicity by Jan Van Lunzen 2009-11-11 32 minutes
2 Clinical Cases by Andrew Scourfield 2009-11-11 6 minutes	Hepatitis Co-Infection by Jürgen Rockstroh 2009-11-11 20 minutes

Opening Ceremony

5 presentations / courses

Welcome by Peter Reiss 2009-11-11 3 minutes	Welcome by Jürgen Rockstroh 2009-11-11 15 minutes
The History and Future of Basic Science in HIV by Francoise Barre-Sinoussi 2009-11-11 29 minutes	Stronger Together, Partnering in Fighting the HIV Epidemic by Nikos Dedes 2009-11-11 14 minutes
Earlier Recognition of HIV: A Pressing Need by Jens Lundgren 2009-11-11 13 minutes

HIV Pathogenesis

2 presentations / courses

HIV Pathogenesis
by Frank Kirchhoff

2009-11-12 30 minutes

Award for Excellence in HIV
by Veronica Miller

2009-11-12 10 minutes

Management of HIV Disease: Trends and Future Prospects

1 presentation / course

Management of HIV Disease: Trends and Future Prospects
by Peter Hunt

2009-11-12 29 minutes

Malignancies

7 presentations / courses

Frequent detection of multiple, oncogene expressing high risk HPV types in an... by Andrea De Luca 2009-11-12 9 minutes	Characteristics of non-AIDS defining malignancies in the HAART era: a clinic... by Stephane De Wit 2009-11-12 5 minutes
Survival and prognostic factors associated with non-AIDS defining malignancie... by Csaba Kosa 2009-11-12 7 minutes	HIV-associated Hodgkin.s lymphoma (HIV-HL): interim analysis of a prospective... by Marcus Hentrich 2009-11-12 8 minutes
Highly active antiretroviral therapy regimens on the prevalence of anal human... by Sebastian Videla 2009-11-12 7 minutes	Possible role of chemokine co-receptors in human polyoma virus (HPOV) cell in... by Radka Argirova 2009-11-12 13 minutes
Progressive multifocal leukoencephalopathy (PML) in AIDS patients receiving p... by JL Casado 2009-11-12 8 minutes

Hepatitis Co-Infection

8 presentations / courses

Efficacy of tenofovir plus emtricitabine compared to emtricitabine based HAAR... by Anchalee Avihingsanon 2009-11-12 11 minutes	Epidemiological and virological characteristics of chronic HBV infection in H... by Vincent Soriano 2009-11-12 10 minutes
Has the uptake of treatment for chronic hepatitis C virus infection (CHC) in ... by Amanda Mocroft 2009-11-12 9 minutes	Rapid virological response (RVR) during treatment of acute HCV infection (AHC... by Martin Vogel 2009-11-12 10 minutes
High HIV prevalence in male patients with acute hepatitis A in the Rome metro... by Enrico Girardi 2009-11-12 9 minutes	Hepatitis delta in HIV-1 infected Romanian adolescents by Cristiana Anca Oprea 2009-11-12 17 minutes
Prevalence of primary drug resistance in hepatitis B virus in newly diagnosed... by Paula Tuma 2009-11-12 5 minutes	Hepatitis C co-infection sensitizes CD4+ T cells towards Fas-induced apoptosi... by Christian Körner 2009-11-12 7 minutes

Joint EACS/IAS Special Session on Harm Reduction: What Clinicians Need to Know About Injecting...

4 presentations / courses

Introduction to EACS/IAS Special Sessions on Harm Reduction / E. Europe by Craig McClure 2009-11-11 11 minutes	Scaling up HAART Coverage to Curb HIV and AIDS in Injecting Drug Users by Julio Montaner 2009-11-12 17 minutes
Advancing Harm Reduction in Europe . What has Worked ? by Patrizia Carrieri 2009-11-12 17 minutes	Consequences of International Drug Policy for Injecting Drug Users and the HI... by Vladimir Mendelevich 2009-11-12 10 minutes

EATG Session: Treating HIV Positive People Injecting Drugs in Europe: Best Practices for a...

4 presentations / courses

Statement from the Community by Olga Byelyayeva to be announced!	IDUs/HIV in Europe: The Available Data by Lucas Wiessing 2009-11-12 13 minutes
The ARUD Zurich (Association for Risk Reduction in Drug) Model by Philip Bruggmann 2009-11-12 11 minutes	The Swiss State-of-Art and Research on Comprehensive Treatments for HIV+ Subs... by Rainer Weber 2009-11-12 15 minutes

Best Poster Discussion 1

8 presentations / courses

HIV-related Hodgkin lymphoma in the era of HAART: incidence and survival in a... by Julia Bohlius 2009-11-12 2 minutes	Treatment of HIV-associated lymphoma in the era of highly active antiretrovir... by Christoph Wyen 2009-11-12 4 minutes
Epidemiology of HIV/STI in the border region Vienna/Austria: results of the B... by Klaus Jansen 2009-11-12 4 minutes	Antiretroviral prophylaxis following sexual exposure to HIV in Italy by Vincenzo Puro 2009-11-12 3 minutes
Cost-effectiveness of pre-exposure prophylaxis for HIV in a MSM population by Jonathan Anderson 2009-11-12 5 minutes	The trouble with bleeding: why do HIV-positive gay men get hepatitis C? by Axel J. Schmidt 2009-11-12 4 minutes
Non-nucleoside analogs use with rifapicin in HIV-infected patients with tuber... by Judith Villar García 2009-11-12 3 minutes	The long-term safety of vicriviroc by Christian Hoffmann 2009-11-12 2 minutes

Antiretroviral Therapy I

8 presentations / courses

Non-inferior efficacy shown across different efficacy endpoints in the MONET ... by Diego Ripamonti 2009-11-12 12 minutes	Use of twice daily darunavir as a substitution for dual boosted PIs in virolo... by Calvin Cohen 2009-11-12 11 minutes
Efficacy and safety of lopinavir/ritonavir monotherapy vs. standard of care c... by Pedro Cahn 2009-11-12 7 minutes	A phase II, open-label trial in treatment-naÃƒÂ¯, HIV-1 infected subjects who... by Pedro Cahn 2009-11-12 11 minutes
Once daily single agent therapy with LPV(r) in subjects virologically suppres... by Joseph Gathe, Jr. 2009-11-12 11 minutes	Atazanavir/ritonavir monotherapy for maintenance of virologic suppression: 48... by Federico Pulido 2009-11-12 7 minutes
Initiating antiretroviral therapy in HIV-infected subjects with CD4 between 3... by Myriam Garrido 2009-11-12 9 minutes	Mini Lecture: Pros and Cons of Boosted PI Monotherapy by José R. Arribas 2009-11-12 17 minutes

Complications of HIV and HIV Treatment I

8 presentations / courses

Mini Lecture: Mental Illness in the Era of Successful HIV Treament by Jordi Blanch 2009-11-12 14 minutes	Do doctors take neuropsychiatric disorders into account at the time of starti... by Enric Pedrol Clotet 2009-11-12 4 minutes
Treatment modification in HIV-infected individuals starting combination antir... by Luigia Elzi 2009-11-12 8 minutes	Prevalence and risk factors of osteopenia and osteoporosis in HIV 1 infected ... by Murielle Mary-Krause 2009-11-12 8 minutes
Effect of alendronate on HIV related osteoporosis: a randomised, double-blind... by Michelle Bentata 2009-11-12 7 minutes	Prevalence and time-course of tenofovir (TDF)-associated tubular proteinuria ... by Hans-Jürgen Stellbrink 2009-11-12 10 minutes
Urinary albumin and retinol-binding protein as markers of glomerular and tubu... by Frank Post 2009-11-12 11 minutes	Interruption of ART for more than 6 months results in poorer CD4 T-cell recov... by Manuel Battegay 2009-11-12 9 minutes

Epidemiology

8 presentations / courses

Mini Lecture: Causes of Death in HIV Infected Patients by Bruno Ledergerber 2009-11-12 15 minutes	Improvements in all-cause mortality across Europe 2002-2007 and regional diff... by Amanda Mocroft 2009-11-12 8 minutes
Mortality rates of elderly HIV-infected adult treated with antiretroviral are... by Charlotte Lewden 2009-11-12 9 minutes	Mortality due to cancer in HIV-infected patients compared to the Italian gene... by Vincenzo Spagnuolo 2009-11-12 8 minutes
Risk of specific AIDS and non-AIDS defining cancers according to immunodefici... by Marguerite Guiguet 2009-11-12 8 minutes	Continuing decline in incidence of central nervous system (CNS) events in the... by Lucy Garvey 2009-11-12 10 minutes
Estimating AIDS and non-AIDS related deaths for patients with missing death d... by Justyna Kowalska 2009-11-12 11 minutes	Diabetes incidence and risk factors over 9-year follow-up after first PI init... by Vincent Bouteloup 2009-11-12 7 minutes

Screening for Non-AIDS Malignancies: If and How?

1 presentation / course

Screening for Non-AIDS Malignancies: If and How?
by Mark Bower

2009-11-13 24 minutes

Diagnosis and Management of Cognitive Disorders During Successful HIV Treatment

1 presentation / course

Diagnosis and Management of Cognitive Disorders During Successful HIV Treatment
by Renaud Du Pasquier

2009-11-13 25 minutes

EACS Guidelines: What is New? Why New Guidelines? Aims, Differences from Past Version

4 presentations / courses

Introduction by Manuel Battegay 2009-11-13 3 minutes	Antiretrovirals by Nathan Clumeck 2009-11-13 11 minutes
Comorbidity by Jens Lundgren 2009-11-13 15 minutes	Hepatitis Viruses by Sanjay Bhagani 2009-11-13 13 minutes

Tuberculosis/Other Infections

7 presentations / courses

Risk factors of immune reconstitution inflammatory syndrome (IRIS) after HAA... by Nontakan Nuntachit 2009-11-13 8 minutes	Asymptomatic gonococcal and Clamydia infections in HIV-negative and HIV-posit... by Heiko Jessen to be announced! (Waiting for speaker approval)
CD4 count, viral suppression, prophylaxis and the risk of primary pneumocysti... by Hansjakob Furrer 2009-11-13 9 minutes	CD4 count, viral suppression, prophylaxis and the risk of recurrent pneumocys... by Amanda Mocroft 2009-11-13 9 minutes
Health care index (HCI) and outcome following a diagnosis of tuberculosis (TB) by Ole Kirk 2009-11-13 8 minutes	Tuberculosis among HIV-1 infected patients across Europe: change over time an... by Daria Podlekareva 2009-11-13 9 minutes
Randomized, prospective, open-label study to compare the efficacy of treatmen... by Anja Potthoff 2009-11-13 9 minutes

HIV in Pregnancy, Childhood and Adolescence

7 presentations / courses

Mini Lecture: Breastfeeding on ART/What makes Breastfeeding Possible? by Jane Anderson 2009-11-13 15 minutes	Sequential pregnancies in HIV infected women by Saloni Surah 2009-11-13 8 minutes
Use of PCR tests to rule out HIV infection in infants born to HIV-infected mo... by Alexey Kruk 2009-11-13 8 minutes	Lipid alterations in HIV infected adolescents by Daniel Blazquez 2009-11-13 7 minutes
Antiretroviral therapy and bone mineral measurements in HIV-infected children... by Alessandra Viganò 2009-11-13 11 minutes	Psychosocial aspects in a cohort of vertically infected adolescents. Disclosu... by Gabriela Medin 2009-11-13 9 minutes
Simplification of combination antiretroviral regimen improves immunological r... by Alessandra Viganò 2009-11-13 7 minutes

The "HIV in Europe" Initiative: Progress Towards Optimal Testing and Earlier Care

4 presentations / courses

Mini Lecture: How to Estimate the Size of the Infected Population that is Una... by Andrew Phillips 2009-11-13 12 minutes	Mini Lecture: The HIV in Europe Stockholm Conference, 2-3 November 2009: Feed... by Anders Sönnerborg 2009-11-13 14 minutes
Controlling the HIV epidemic in the Netherlands by Frank de Wolf 2009-11-13 12 minutes	Proportion and trend over calendar time of patients with a low CD4 count or A... by Antonella d'Arminio Monforte 2009-11-13 7 minutes

Best Poster Discussion 2

8 presentations / courses

Moving from risk factor assessment to atherosclerosis imaging to select the m... by Giovanni Guaraldi 2009-11-13 6 minutes	Hypertension (HTN) and isolated office hypertension (IOH) in HIV-infected pat... by Jose Ignacio Bernardino 2009-11-13 4 minutes
Effect of a nutritional intervention on CD4+ T cell decline in HIV-1 positive... by Joep Lange 2009-11-13 5 minutes	Long term evolution of a cohort of HIV infected patients older than 60 years ... by Pierre de Truchis 2009-11-13 3 minutes
Efficacy of nevirapine combined with tenofovir-emtricitabine as initial treat... by Pere Domingo 2009-11-13 6 minutes	Time to virologic response (TVR) is not associated with response durability i... by Ramin Ebrahimi 2009-11-13 4 minutes
Viral load outcome after virologic failure of the three original antiretrovir... by Dominique Costagliola 2009-11-13 3 minutes	Correlation between Trofile® test and virological response to a short-term ma... by Miguel Genebat 2009-11-13 4 minutes

Antiretroviral Therapy II

8 presentations / courses

Mini Lecture: Management of Low Level Viraemia by Anna-Maria Geretti 2009-11-13 15 minutes	Mini Lecture: What CD4s don't Tell Us by Brigitte Autran 2009-11-13 15 minutes
Comparison of renal and bone toxicities, and CV serum risk markers, in the as... by Hans-Jürgen Stellbrink 2009-11-13 9 minutes	Simplification with fixed-dose tenofovir-emtricitabine or abacavir-lamivudine... by José Gatell 2009-11-13 9 minutes
Comparison of lipid profile with nevirapine versus atazanavir/ritonavir, both... by Daniel Podzamczer 2009-11-13 8 minutes	Safety and efficacy of the new anchoring inhibitor VIR-576 by Reinhold E. Schmidt 2009-11-13 10 minutes
Immuno-virological response to triple NRTI and boosted PI in treatment-naïve ... by Antoine Bénard 2009-11-13 10 minutes	Both once-daily saquinavir/ritonavir and atazanavir/ritonavir, when combined ... by Saskia Vrouenraets 2009-11-13 10 minutes

Resistance, Pharmacology and Immunology

8 presentations / courses

Mini Lecture: Polypharmacy in Ageing Patients with HIV by Marta Boffito 2009-11-13 14 minutes	The effect of antiretroviral therapy without CCR5-antagonists on HIV-1 tropis... by Carlo - Federico Perno to be announced! (Waiting for speaker approval)
Drug resistance was more important in NRTI-sparing regimen (NNRTI+PI) than in... by Anne-Genevieve Marcelin 2009-11-13 8 minutes	Genotypic prediction of HIV-1 tropism: correlation with the virological respo... by Bernard Masquelier 2009-11-13 10 minutes
Comparison of the use of last genotype versus all past genotypes to classify ... by Philippe Flandre 2009-11-13 8 minutes	Prevalence and relevance of drug-drug interactions in the Swiss HIV cohort study by Catia Marzolini 2009-11-13 11 minutes
Association of a constitutive androstane receptor polymorphism (RS2307424) wi... by Andrew Owen 2009-11-13 10 minutes	Plasmacytoid dendritic cells (PDC) in lymphoid tissues of HIV-1 infected pati... by Clara Lehmann 2009-11-13 12 minutes

Complications of HIV and HIV Treatment II

8 presentations / courses

Feedback from the 11th International Workshop on Adverse Drug Reactions and C... by Stefan Mauss 2009-11-13 16 minutes	Mini Lecture: Basic/Translational Science by Georg Behrens 2009-11-13 16 minutes
Abdominal adiposity remains highly prevalent in French HIV-infected patients ... by François Raffi 2009-11-13 8 minutes	Impact of traditional cardiovascular risk factors and HIV parameters on the r... by Dominique Costagliola 2009-11-13 9 minutes
Fatty liver disease associated with hepatitis C and/or human immunodeficiency... by Giovanni Guaraldi 2009-11-13 13 minutes	Relations between cardiovascular risk estimates and subclinical atheroscleros... by Paolo Maggi 2009-11-13 9 minutes
Inflammatory biomarkers predict cardiovascular events in HIV positive patient... by Andrea De Luca 2009-11-13 10 minutes	Body composition changes in treatment-naive patients treated with boosted PIs... by Graeme Moyle 2009-11-13 13 minutes

Sexual Health for Persons Living with HIV

1 presentation / course

Sexual Health for Persons Living with HIV
by Fiona Mulcahy

2009-11-14 25 minutes

Special Session: Hepatitis C New Drugs (in Co-Infected Patients)

5 presentations / courses

Introduction by Bernard Hirschel 2009-11-14 2 minutes	HCV: Molecular Biology of HCV, an Introduction for Health Care Professionals by Heiner Wedemeyer to be announced! (Waiting for speaker approval)
Why We Need New Drugs for Hepatitis C, Particularly in HIV/HCV Co-Infection by Mark Nelson 2009-11-14 20 minutes	Future Treatment Options for Hepatitis C by Yves Benhamou 2009-11-14 23 minutes
HCV/HIV Co-infection: Safety and Regulatory Issues for Drug Development by Nathalie Morgensztejn 2009-11-14 14 minutes

The Threat of Drug Resistant Tuberculosis in Eastern Europe

1 presentation / course

The Threat of Drug Resistant Tuberculosis in Eastern Europe
by Alexander Panteleev

2009-11-14 18 minutes

Closing

4 presentations / courses

Hot News from the HIV Vaccine Field by Yves Lévy to be announced! (Waiting for speaker approval)	Closing by Peter Reiss 2009-11-14 3 minutes
13th European AIDS Congress/EACS Belgrade by Panel Discussion to be announced!	13th European AIDS Congress/EACS Belgrade by Gordana Dragovic Lukic 2009-11-14 4 minutes

Search’n Build™